Literature DB >> 17933388

Genistein inhibits contractile force, intracellular Ca2+ increase and Ca2+ oscillations induced by serotonin in rat aortic smooth muscle.

F Speroni1, A Rebolledo, S Salemme, M C Añón, F Tanzi, V Milesi.   

Abstract

The soy-derived isoflavones genistein and daidzein affect the contractile state of different kinds of smooth muscle. We describe acute effects of genistein and daidzein on contractile force and intracellular Ca2+ concentration ([Ca2+]i) in in situ smooth muscle of rat aorta. Serotonin (5-HT) (2 microM) or a depolarizing high K+ solution produced the contraction of aortic rings, which were immediately relaxed by 20 microM genistein and by 20 microM daidzein. Accordingly, both 5-HT and a high K+ solution increased the [Ca2+]i in in situ smooth muscle cells. Genistein strongly inhibited the [Ca2+]i increase evoked by 5-HT (74.0 +/- 7.3%, n = 11, p < 0.05), and had a smaller effect on high K+ induced [Ca2+]i increase (19.9 +/- 4.0%, n = 7, p < 0.05). The K+ channels blocker tetraethylammonium (TEA) (0.5 mM) diminished genistein effects on 5-HT-induced [Ca2+]i increase. Interestingly, during prolonged application of 5-HT, the [Ca2+]i oscillated and a short (90 s) preincubation with genistein (20 microM) significantly diminished the frequency of the oscillations. This effect was totally abolished by TEA. In conclusion, in rat aortic smooth muscle, genistein is capable of diminishing the increase in [Ca2+]i and in force evoked by 5-HT and high K+ solution, and of decreasing the frequency of [Ca2+]i oscillations induced by 5-HT. The short time required by genistein, and the relaxing effect of daidzein suggest that tyrosine kinases inhibition is not involved. The small inhibiting effect of genistein on the [Ca2+]i increase evoked by high K+ and the effect of TEA point to the activation by genistein of calcium-activated K+ channels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17933388     DOI: 10.1007/bf03168225

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  18 in total

1.  Use and specificity of genistein as inhibitor of protein-tyrosine kinases.

Authors:  T Akiyama; H Ogawara
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Genistein sensitivity of calcium transport pathways in serotonin-activated vascular smooth muscle cells.

Authors:  S R Nelson; T Chien; J Di Salvo
Journal:  Arch Biochem Biophys       Date:  1997-09-01       Impact factor: 4.013

3.  Integration of mitogen-activated protein kinase kinase activation in vascular 5-hydroxytryptamine2A receptor signal transduction.

Authors:  J A Florian; S W Watts
Journal:  J Pharmacol Exp Ther       Date:  1998-01       Impact factor: 4.030

4.  Calcium-sensitive potassium channel inhibitors antagonize genistein- and daidzein-induced arterial relaxation in vitro.

Authors:  R Nevala; K Paukku; R Korpela; H Vapaatalo
Journal:  Life Sci       Date:  2001-08-10       Impact factor: 5.037

5.  Genistein reduces agonist-induced contractions of porcine coronary arterial smooth muscle in a cyclic AMP-dependent manner.

Authors:  Mary Y K Lee; Susan W S Leung; Paul M Vanhoutte; Ricky Y K Man
Journal:  Eur J Pharmacol       Date:  2004-10-25       Impact factor: 4.432

6.  Genistein, a specific inhibitor of tyrosine-specific protein kinases.

Authors:  T Akiyama; J Ishida; S Nakagawa; H Ogawara; S Watanabe; N Itoh; M Shibuya; Y Fukami
Journal:  J Biol Chem       Date:  1987-04-25       Impact factor: 5.157

7.  Tyrosine kinase inhibitor, genistein, inhibits macroscopic L-type calcium current in rat portal vein smooth muscle cells.

Authors:  H Liu; K Li; N Sperelakis
Journal:  Can J Physiol Pharmacol       Date:  1997-09       Impact factor: 2.273

8.  Tyrosine kinases modulate the activity of single L-type calcium channels in vascular smooth muscle cells from rat portal vein.

Authors:  H Liu; N Sperelakis
Journal:  Can J Physiol Pharmacol       Date:  1997-09       Impact factor: 2.273

9.  Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.

Authors:  G G Kuiper; J G Lemmen; B Carlsson; J C Corton; S H Safe; P T van der Saag; B van der Burg; J A Gustafsson
Journal:  Endocrinology       Date:  1998-10       Impact factor: 4.736

10.  Modulation of Ca2+ sensitivity in smooth muscle by genistein and protein tyrosine phosphorylation.

Authors:  A Steusloff; E Paul; L A Semenchuk; J Di Salvo; G Pfitzer
Journal:  Arch Biochem Biophys       Date:  1995-07-10       Impact factor: 4.013

View more
  3 in total

Review 1.  Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease.

Authors:  V B Gencel; M M Benjamin; S N Bahou; R A Khalil
Journal:  Mini Rev Med Chem       Date:  2012-02       Impact factor: 3.862

2.  Genistein effects on Ca2+ handling in human umbilical artery: inhibition of sarcoplasmic reticulum Ca2+ release and of voltage-operated Ca2+ channels.

Authors:  F Speroni; A Rebolledo; S Salemme; R Roldán-Palomo; L Rimorini; M C Añón; A Spinillo; F Tanzi; V Milesi
Journal:  J Physiol Biochem       Date:  2009-06       Impact factor: 4.158

3.  The differential effects of a selective kappa-opioid receptor agonist, U50488, in guinea pig heart tissues.

Authors:  Chi-Feng Hung; Hsin-Ju Li; Hsun-Hao Chang; Gon-Ann Lee; Ming Jai Su
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.